Defense World
01 Jan 2026, 10:24 UTC · 37w ago
Verdict
Headline takes no side. We score MRUS +0.30 across two claims — moderately bullish.
+0.30moderately bullish
More positive than 57% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Major shareholder A/S Genmab purchased 2,978 shares of Merus (MRUS) at an average price of $97.00 per share.
More positive than 41% of claims this week
A/S Genmab holds a dominant position in Merus with a total of 72,831,487 shares owned.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Near neutral — 99% of claims this week are stronger
Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+0.0%
Price flat so far
$90.00 vs $90.00 close before publication (Dec 31) · not market-adjusted
MRUS chart →
